GLENMARK LIFE SCIENCES LIMITED

Scale -

Ebitda is 858 Rs Cr; Annual Growth is 20 %; Continuous Growth over 3 years; in Top Quartile
PAT is 564 Rs Cr; Annual Growth is 16 %; Continuous Growth over 3 years; in Top Quartile
Revenue is 2552 Rs Cr; Continuous Growth over 3 years; in Top Quartile
PBT is 212 Rs Cr; in Top Quartile
Quarterly Revenue is 640 Rs Cr; in Top Quartile

Quarterly Ebitda is 212 Rs Cr; Continuous Decline over 3 Quarters

Profitability -

Quarterly Profit margin is 25 %; Continuous Growth over 3 Quarters; in Top Quartile
PBDIT Margin is 33.61 %; in Top Quartile
PAT Margin is 22.12 %; in Top Quartile
Quarterly Ebitda Margin is 33 %; in Top Quartile

Return -

ROCE is 22.51 %; in Top Quartile
ROA is 14.17 %; in Top Quartile; Continuous Decline over 3 years
ROE is 16.94 %; in Top Quartile; Continuous Decline over 3 years

Asset Turnover is 69 %; Continuous Decline over 3 years

Efficiency -

Operating cash flow is 565 Rs Cr; Annual Growth is 44 %; in Top Quartile
Current Ratio is 5.21; Continuous Growth over 3 years; in Top Quartile
Quick Ratio is 3.85; Continuous Growth over 3 years; in Top Quartile

Solvancy -

Debt/Equity is 0; in Bottom Quartile
Total Debt is 0 Rs Cr; in Bottom Quartile

Contingent Liabilities is 110 Rs Cr; Annual Growth is 191 %; Continuous Growth over 3 years; 5 Year CAGR is 22 %

Quality -

Operating cashflow/ebitda is 66 %; Annual Growth is 21 %
Operating cashflow/PAT is 100 %; Annual Growth is 24 %
Change in Inventories/Total Expenses is 0 %; Annual Decline is -87 %; 5 Year CAGR is -48 %
Exceptional Items/PBT is -3 %; in Bottom Quartile

Other Expenses/Total Expenses is 22 %; Continuous Growth over 3 years

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector

Major Subsidiaries/Associates

Key Clients

Products

Products

Product details

Operations

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search: